Efficacy and Safety of Combination Ambrisentan and Tadalafil in Patients With Portopulmonary Hypertension
Clinical trial NCT03309592 · WITHDRAWN
Trial details
- NCT number
- NCT03309592
- Sponsor
- Ochsner Health System
- Status
- WITHDRAWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-12
- Primary completion
- 2018-11-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.